Clinical Trial Update: Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis [Phase 2]

View source ↗

Summary

A randomized Phase 2 study comparing Genz-644470, placebo, and sevelamer carbonate in chronic kidney disease patients on hemodialysis completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Genz-644470
• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Kidney Failure, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2015-05-01